Éter diglicídico de resorcinol
ANVISA lists this substance among materials that may not be used in personal-hygiene products, cosmetics or perfumes in Brazil.
Décision réglementaire et conditions complètes
- Statut
- Prohibited
- Rôle juridique
- Binding rule
- Résumé réglementaire
- ANVISA lists this substance among materials that may not be used in personal-hygiene products, cosmetics or perfumes in Brazil.
- Conditions et restrictions
Éter diglicídico de resorcinol
Identité de la substance
- Nom dans la source officielle
- Éter diglicídico de resorcinol
- CAS
- 101-90-6
- EC
- 202-987-5
- Correspondance d’identité
- standalone:official_anvisa_record
Aperçu multi-marchés pour cette identité
Fiches exactes associées actuellement présentes sur ce site. L’absence d’un marché signifie qu’aucune correspondance exacte n’a été importée, et non une autorisation d’utiliser la substance.
European Union
1 fiche associée
Ouvrir la fiche justificativeGreat Britain
1 fiche associée
Ouvrir la fiche justificativeNew Zealand
1 fiche associée
Ouvrir la fiche justificativeASEAN
1 fiche associée
Ouvrir la fiche justificativeChina
1 fiche associée · 1 avec conditions spécifiques
Ouvrir la fiche justificativeSouth Korea
1 fiche associée
Ouvrir la fiche justificativeBrazil
Fiche actuelle1 fiche associée · 1 avec conditions spécifiques
Ouvrir la fiche justificativeIndia
1 fiche associée · 1 avec conditions spécifiques
Ouvrir la fiche justificativeSaudi Arabia
1 fiche associée
Ouvrir la fiche justificative
Chimie vérifiée pour le CAS 101-90-6
Resorcinol diglycidyl ether
Diglycidyl resorcinol ether is an aromatic ether. — ChEBI
- Nom IUPAC
- 2-[[3-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane
- Formule moléculaire
- C12H14O4
- Masse moléculaire
- 222.24 g/mol
- Masse exacte
- 222.08920892 Da
- Masse monoisotopique
- 222.08920892 Da
- XLogP3
- 1,2
- Surface polaire topologique
- 43,5 Ų
- Complexité moléculaire
- 211,0
- Charge formelle
- 0
- Donneurs de liaisons hydrogène
- 0
- Accepteurs de liaisons hydrogène
- 4
- Liaisons rotatives
- 6
- Atomes lourds
- 16
- Unités covalentes
- 1
Noms et synonymes signalés à PubChem
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:82318
- ChEMBL:CHEMBL1338613
- EPA DTXSID:DTXSID2020470
- PubMed:22029968
- PubMed:12748690
- PubMed:3768853
- PubMed:2276701
Statistiques de structure avancées
- Stéréocentres atomiques définis
- 0
- Stéréocentres atomiques non définis
- 2
- Stéréocentres de liaison définis
- 0
- Stéréocentres de liaison non définis
- 0
- Caractéristiques pharmacophoriques 3D
- 5
- Cycles 3D
- 1
- Groupes hydrophobes 3D
- 0
- Caractéristiques d’accepteur 3D
- 4
- Caractéristiques de donneur 3D
- 0
- Centres anioniques 3D
- 0
- Centres cationiques 3D
- 0
- Conformères 3D
- 10
- Rotors 3D effectifs
- 7,2
Identifiants de structure lisibles par machine
- SMILES
C1C(O1)COC2=CC(=CC=C2)OCC3CO3- InChI
InChI=1S/C12H14O4/c1-2-9(13-5-11-7-15-11)4-10(3-1)14-6-12-8-16-12/h1-4,11-12H,5-8H2- InChIKey
WPYCRFCQABTEKC-UHFFFAOYSA-N
Preuves issues de bases de données scientifiques complémentaires
EMBL-EBI ChEBI
Diglycidyl resorcinol ether
- Formule
- C12H14O4
- Masse moyenne
- 222.240 g/mol
- Masse monoisotopique
- 222.08921 Da
- Charge formelle
- 0
- aromatic ether — is a (CHEBI:35618)
- aromatic ether — is a (CHEBI:35618)
Références croisées de cette source
- CAS: 101-90-6 — KEGG COMPOUND
- MANUAL_X_REF: C19228 — KEGG COMPOUND
Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Récupéré le: 2026-08-31. Ouvrir la fiche source
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 342 °F at 0.8 mmHg (NTP, 1992) Source: CAMEO Chemicals
- Boiling Point: 172 °C @ 0.8 MM HG Source: Hazardous Substances Data Bank (HSDB)
- Boiling Point: at 0.0001kPa: 172 °C Source: ILO-WHO International Chemical Safety Cards (ICSCs)
- Color/Form: STRAW-YELLOW LIQUID Source: Hazardous Substances Data Bank (HSDB)
- Density: 1.21 at 77 °F (NTP, 1992) - Denser than water; will sink Source: CAMEO Chemicals
- Density: SP GR: 1.21 @ 25 °C Source: Hazardous Substances Data Bank (HSDB)
- Density: Relative density (water = 1): 1.21 Source: ILO-WHO International Chemical Safety Cards (ICSCs)
- Flash Point: 350 °F (NTP, 1992) Source: CAMEO Chemicals
- Flash Point: 113 °C Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Flash Point: 350 °F (OPEN CUP) Source: Hazardous Substances Data Bank (HSDB)
- Flash Point: 113 °C c.c. Source: ILO-WHO International Chemical Safety Cards (ICSCs)
- Melting Point: 98 to 115 °F (NTP, 1992) Source: CAMEO Chemicals
- Melting Point: 32 TO 33 °C Source: Hazardous Substances Data Bank (HSDB)
- Melting Point: 32-33 °C Source: ILO-WHO International Chemical Safety Cards (ICSCs)
- Odor: SLIGHT PHENOLIC ODOR Source: Hazardous Substances Data Bank (HSDB)
- Physical Description: Diglycidyl resorcinol ether appears as clear yellow or straw-yellow viscous liquid. Boiling point 172 °C; density 1.21 g / cm3. Possible carcinogen. Source: CAMEO Chemicals
- Physical Description: Liquid Source: EPA Chemical Data Reporting (CDR)
- Physical Description: Yellow paste or liquid; [ICSC] Light yellow liquid; [MSDSonline] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: YELLOW PASTE OR LIQUID WITH CHARACTERISTIC ODOUR. Source: ILO-WHO International Chemical Safety Cards (ICSCs)
- Refractive Index: INDEX OF REFRACTION: 1.541 @ 25 °C/D Source: Hazardous Substances Data Bank (HSDB)
- Solubility: less than 0.1 mg/mL at 64 °F (NTP, 1992) Source: CAMEO Chemicals
- Solubility: Miscible with most org resins Source: Hazardous Substances Data Bank (HSDB)
- Vapor Pressure: 40.7 mmHg at 77 °F ; 54.6 mmHg at 108 °F (NTP, 1992) Source: CAMEO Chemicals
- Vapor Pressure: 40.7 [mmHg] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Vapor Pressure: VAPOR PRESSURE LOW Source: Hazardous Substances Data Bank (HSDB)
- Viscosity: 500 CENTIPOISES (25 °C) Source: Hazardous Substances Data Bank (HSDB)
- IARC Carcinogenic Agent: Diglycidyl resorcinol ether Source: International Agency for Research on Cancer (IARC)
- IARC Carcinogenic Classes: Group 2B: Possibly carcinogenic to humans Source: International Agency for Research on Cancer (IARC)
- IARC Monographs: Volume 36: (1985) Allyl Compounds, Aldehydes, Epoxides and Peroxides; Volume Sup 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, 1987; 440 pages; ISBN 92-832-1411-0 (out of print); Volume 71: (1999) Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Part 1, Part 2, Part 3) Source: International Agency for Research on Cancer (IARC)
- Publication Year: 1999 Source: International Agency for Research on Cancer (IARC)
- Evaluation Year: 1998 Source: International Agency for Research on Cancer (IARC)
- Substance: Diglycidyl resorcinol ether (DGRE) Source: NTP Technical Reports
- NTP Technical Report: TR-257: Toxicology and Carcinogenesis Studies of Diglycidyl Resorcinol Ether (Technical Grade) (CASRN 101-90-6) In F344/N Rats and B6C3F1 Mice (Gavage Studies) (1986 ) Source: NTP Technical Reports
- Peer Review Date: 02/28/83 Source: NTP Technical Reports
- Conclusion for Male Rat: Clear Evidence Source: NTP Technical Reports
- Conclusion for Female Rat: Clear Evidence Source: NTP Technical Reports
- Conclusion for Male Mice: Clear Evidence Source: NTP Technical Reports
- Conclusion for Female Mice: Clear Evidence Source: NTP Technical Reports
- Exposure Routes: The substance can be absorbed into the body through the skin and by ingestion. Source: ILO-WHO International Chemical Safety Cards (ICSCs)
- First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. IMMEDIATELY call a hospital or poison control center even if no symptoms (such as redness or irritation) develop. IMMEDIATELY transport the victim to a hospital for treatment after washing the affected areas.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknow Source: CAMEO Chemicals
- Signal: Danger Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H311: Toxic in contact with skin [Danger Acute toxicity, dermal]; H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H350: May cause cancer [Danger Carcinogenicity]; H412: Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Precautionary Statement Codes: P203, P261, P262, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P316, P318, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P405, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Signal: Danger Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H311 (26.8%): Toxic in contact with skin [Danger Acute toxicity, dermal]; H312 (73.2%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H341 (100%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H350 (26.8%): May cause cancer [Danger Carcinogenicity]; H351 (73.2%): Suspected of causing cancer [Warning Carcinogenicity]; H372 (22.6%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H373 (22.6%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]; H412 (94.6%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P260, P261, P262, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P316, P317, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 504 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Signal: Danger Source: NITE-CMC
- GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity] Source: NITE-CMC
- Precautionary Statement Codes: P203, P280, P318, P405, and P501 (click each P-code to see the statement) Source: NITE-CMC
- Signal: Warning Source: NITE-CMC
- GHS Hazard Statements: H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H351: Suspected of causing cancer [Warning Carcinogenicity] Source: NITE-CMC
- Consumer Uses: Viscosity modifiers; Dispersing agent Source: EPA Chemical Data Reporting (CDR)
- Industry Uses: Viscosity modifiers; Intermediate; Dispersing agent Source: EPA Chemical Data Reporting (CDR)
- Sources/Uses: Used in epoxy resins and as a curing agent for polysulfide rubber; [HSDB] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Industrial Processes with risk of exposure: Plastic Composites Manufacturing [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: Epoxy resins Source: Hazardous Substances Data Bank (HSDB)
- Uses: CURING AGENT FOR POLYSULFIDE RUBBER Source: Hazardous Substances Data Bank (HSDB)
- Uses: ... AS LIQUID EPOXY RESIN & AS REACTIVE DILUENT IN PRODN OF OTHER EPOXY RESINS. Source: Hazardous Substances Data Bank (HSDB)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| EMBL-EBI ChEBI | Correspondance exacte | 2026-08-31 |
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Source officielle et provenance
- Source enregistrée
- Brazil ANVISA consolidated prohibited substances — RDC 529/2021 through RDC 1.030/2026
- Référence de la source
- RDC 529/2021 consolidated annex, entry 992 (through RDC 1.030/2026)
- Identifiant de la fiche source
annex:992- Version de la source
- RDC 529/2021 consolidated through RDC 1.030/2026
- Langue de la source
- Portuguese with official English identity where published
- État de la traduction
- Official English translation · Traduction anglaise
- Date d’effet
- 2026-06-15
- Source mise à jour le
- 2026-06-15
- Instantané vérifié le
- 2026-08-31 15:26 UTC
- Méthode de validation
- pdfplumber government baseline + 4 RDC 1.030 exclusions + 15 additions; 1,387 substantive rows
- SHA-256
a212e85540a186a842664fbdd4f351af0b1b4baeeb0c4765b9b52c6ce91c1e84
Notes du jeu de données enregistré
- Couverture du jeu de données
- All 1,387 substantive current prohibited rows after applying RDC 1.030/2026 additions, amendments and exclusions to RDC 529/2021
- Note sur l’autorité
- Binding consolidated prohibited list for personal-hygiene products, cosmetics and perfumes
Place de cette fiche dans le jeu de données du marché
Répartition des statuts
Un texte de conditions est présent pour 1387 des 1387 fiches actuelles. Un champ de conditions vide est interprété selon le type de fiche ci-dessus ; il n’est jamais converti en une affirmation d’utilisation sans restriction.
Brazil contexte du marché
Complete prohibited dataset plus current restricted-list workflow
Version de la couverture : ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
All 1,387 substantive current prohibited rows in RDC 529/2021 consolidated through RDC 1.030/2026, plus the current RDC 1.029 restricted-list and identity workflow.
Liste de contrôle de vérification
- Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
- Check the consolidated prohibited list including RDC 1.030/2026 changes.
- Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
- Verify Mercosur incorporation, regularisation, labelling and transition periods.
Sources officielles du marché
- Brazil ANVISA INCI translation panelIdentity and labelling crosswalk only; regulatory lists must be sourced separately
- Brazil ANVISA restricted substances — RDC 1.029/2026Binding ANVISA resolution effective on publication; replaced RDC 530/2021 for this list part
- Brazil ANVISA consolidated prohibited substances — RDC 529/2021 through RDC 1.030/2026Binding consolidated prohibited list for personal-hygiene products, cosmetics and perfumes
Procédure de vérification et exhaustivité de la fiche
Avant d’utiliser ce résultat dans une décision de conformité
- Confirmez que « Éter diglicídico de resorcinol » et chaque identifiant CAS/CE correspondent à la matière de votre spécification fournisseur.
- Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
- Check the consolidated prohibited list including RDC 1.030/2026 changes.
- Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
- Verify Mercosur incorporation, regularisation, labelling and transition periods.
- Consignez la version de la source et revérifiez auprès de l’autorité de réglementation avant la fabrication, la notification ou la mise sur le marché.
Champs disponibles dans cette fiche
- Nom officiel de la substanceDisponible
- CASDisponible
- ECDisponible
- Texte de condition distinctDisponible
- Date d’effetDisponible
- Empreinte de l’instantané et méthodeDisponible
Questions auxquelles cette page répond
Citation stable
Éter diglicídico de resorcinol. RDC 529/2021 consolidated annex, entry 992 (through RDC 1.030/2026). Brazil. Source version RDC 529/2021 consolidated through RDC 1.030/2026. CosIng Checker regulatory record: https://cosingchecker.com/fr/regulations/br/records/14192/
Citez l’autorité de réglementation comme autorité juridique. Cette page est un index structuré de preuves et une aide à la vérification, et non un substitut au texte officiel ni à une évaluation juridique professionnelle.
Interprétation et limites pour Brazil
This official record identifies the substance as prohibited for cosmetic use in the stated market scope.
Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.
Comment interpréter le rôle juridique
The cited row forms part of a binding rule or legally incorporated list for this market.
Preuves sur cette page
- Résultat enregistré : Prohibited
- Rôle juridique : Binding rule
- Version de la source : RDC 529/2021 consolidated through RDC 1.030/2026
- Date d’effet : 2026-06-15
Ce que cela ne prouve pas
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
Recherche complémentaire sur la substance auprès de sources faisant autorité
Aucune de ces sources ne prévaut sur la décision de marché ci-dessus.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Rechercher cette identité à la sourceFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Rechercher cette identité à la sourceILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Rechercher cette identité à la sourceJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Rechercher cette identité à la sourceNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Rechercher cette identité à la sourceOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Rechercher cette identité à la sourceUS EPA CompTox CTX APIs
Clé d’API requise pour l’importDTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Rechercher cette identité à la source